西藏珠峯(600338.SH)不能如期實施2019年第三季度利潤分配方案
格隆匯6月9日丨西藏珠峯(600338.SH)公佈,公司主要經營實體——在境外的全資子公司塔中礦業有限公司(“塔中礦業”)受新冠肺炎疫情影響,生產經營和運營資金壓力加大。公司現階段的防疫抗疫和維護健康安全急需資金保障,過渡到後疫情階段的維持運營和全面復產也需要資金支持,而目前的經營性現金流和外部融資均進展不順。基於上述考慮,公司不能如期實施2019年第三季度利潤分配方案。
公司正在積極應對當前暫時的困難,待塔中礦業生產運營恢復正常,公司運營資金週轉平穩後,再及早向全體股東實施該分配方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.